Director, Health Economics – Outcomes Research, ARGO Franchise

🕒 2 dias atrás

🇺🇸 Estados Unidos – Remoto (EUA)

⏰ Tempo Integral

🔴 Especialista

👔 Diretor

🦅 Patrocina Visto H1B

Esta empresa já patrocinou vistos H1B no passado.

Candidatar-se

Encontrar Vagas Remotas Similares

Configurar Alerta de Email para Novas Vagas

📊 Verifique sua pontuação de currículo para esta vaga

Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

Enviar Currículo

Azurity Pharmaceuticals

SiteLinkedInTodas as Vagas

201 - 500 funcionários

🏥 Saúde

🏭 Manufatura

💊 Farmacêutico

💰 Private Equity Round em 2015-01

Healthcare • Manufacturing • Pharmaceuticals

A Azurity Pharmaceuticals é uma empresa farmacêutica especializada e de propriedade privada que se concentra em produtos inovadores destinados a atender às necessidades de pacientes com condições não atendidas. Como líder do setor no fornecimento de medicamentos únicos, acessíveis e de alta qualidade, a Azurity utiliza suas capacidades integradas e vasta rede de parceiros para expandir continuamente seu amplo portfólio de produtos comerciais e seu robusto pipeline em estágio avançado. Os produtos centrados no paciente da empresa abrangem os mercados cardiovascular, neurologia, endocrinologia, gastro-intestinal, institucional e órfão, beneficiando milhões de pacientes.

Descrição

• Own the HEOR and value-evidence strategy for the ARGO franchise, beginning with D-PLEX100 • Build integrated evidence plans supporting US and Canadian access and reimbursement across the product lifecycle • Identify evidence gaps for hospital decision-makers, payers, and HTA bodies and prioritize studies and analyses • Define the economic value proposition for an inpatient, DRG-reimbursed surgical product • Lead AMCP and other value dossiers and supporting clinical and economic evidence summaries • Build and maintain budget-impact, cost-effectiveness, cost-of-care, cost-offset, and account-level value models • Develop payer, hospital, and P&T/value-analysis-committee tools and objection-handling materials • Lead HEOR and evidence components of NTAP and other inpatient add-on payment applications • Develop hospital coding and reimbursement strategy, including MS-DRG, HCPCS, and ICD coding • Model DRG economics and the inpatient payment landscape • Design and oversee retrospective database, real-world evidence, chart review, and pragmatic HEOR studies • Collaborate with clinical, biostatistics, evidence-generation colleagues, KOLs, external vendors, and academic collaborators • Drive HEOR publications and communications for abstracts, posters, and manuscripts • Support US field engagement with payers, hospital systems, IDNs, and population-health decision-makers • Develop Canadian value-evidence and HTA strategy, including CDA-AMC/CADTH and INESSS submissions • Monitor evolving evidence requirements, HTA methods, and ICER-type assessments • Deliver launch-ready dossiers, models, value tools, NTAP support, coding strategy, field enablement, and evidence-generation plans

🎯 Requisitos

• Advanced degree in health economics, outcomes research, pharmacy, epidemiology, public health, or a related field (PhD, PharmD, or Master's); Bachelor's with commensurate experience considered • Minimum 8 years of HEOR, health economics, or value & access experience in pharmaceutical, biotech, or medical device • Demonstrated ownership of value dossiers, including AMCP dossiers, and budget-impact and cost-effectiveness models • Working knowledge of US reimbursement, including inpatient DRG economics, NTAP, and hospital MS-DRG, HCPCS, and ICD coding • Experience designing and overseeing HEOR studies using claims, EHR, and registry data • Experience working with external vendors and academic collaborators • Ability to translate economic analysis into decision-ready value narratives for payer, hospital, and P&T audiences • Proven cross-functional collaboration with Market Access, Medical Affairs, Commercial, and Clinical/Regulatory teams • Willingness to travel approximately 20–30% • Hospital/inpatient, anti-infective, surgical, or drug-device product HEOR experience strongly preferred • Direct NTAP or other inpatient add-on payment pathway experience preferred • Familiarity with hospital P&T, value-analysis committees, antimicrobial-stewardship/infection-prevention economics, and Canadian HTA preferred • Publication record in HEOR or health-economics venues preferred • Must be able to sit for long periods, frequently stand/walk/talk/hear, occasionally climb stairs or ride elevators, lift/move up to 25 pounds, and operate keyboards, telephones, and handheld devices

🏖️ Benefícios

• Competitive compensation package • Annual bonus based on company performance • Medical, dental, vision, and prescription coverage • Remote work arrangement for this role • 401(k) matching dollar for dollar up to 5% • Up to 15 vacation days annually plus rollover of up to 40 hours • Five sick/wellness days • Company closure between Christmas and New Year’s • 13 recognized holidays • Tuition reimbursement for undergraduate and graduate courses or certifications • Azurity High Five peer recognition platform